1 Libby, P (2002) Atherosclerosis: the new view. Sci Am 286, 46–55.
2 Koenig, W, Khuseyinova, N, Baumert, J, et al. (2006) Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Arterioscler Thromb Vasc Biol 26, 2745–2751.
3 Herder, C, Baumert, J, Thorand, B, et al. (2006) Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Arterioscler Thromb Vasc Biol 26, 2147–2152.
4 Tuomisto, K, Jousilahti, P, Sundvall, J, et al. (2006) C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost 95, 511–518.
5 Blake, GJ & Ridker, PM (2003) C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41, 4 Suppl. S, 37S–42S.
6 Hlawaty, H, Jacob, MP, Louedec, L, et al. (2009) Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis. Arterioscler Thromb Vasc Biol 29, 518–524.
7 Ferrante, AW Jr (2007) Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 262, 408–414.
8 Conen, D, Rexrode, KM, Creager, MA, et al. (2009) Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women. A prospective study. Circulation 120, 1041–1047.
9 Rutter, MK, Meigs, JB, Sullivan, LM, et al. (2004) C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110, 380–385.
10 Wellen, KE & Hotamisligil, GS (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112, 1785–1788.
11 Gustafson, B, Hammarstedt, A, Andersson, CX, et al. (2007) Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27, 2276–2283.
12 Kamei, N, Tobe, K, Suzuki, R, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281, 26602–26614.
13 Youn, HS, Lee, JY, Fitzgerald, KA, et al. (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175, 3339–3346.
14 Kang, OH, Jang, HJ, Chae, HS, et al. (2009) Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol Res 59, 330–337.
15 Do, GM, Kwon, EY, Kim, HJ, et al. (2008) Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun 374, 55–59.
16 Wang, Z, Zou, J, Cao, K, et al. (2005) Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med 16, 533–540.
17 Fuhrman, B, Volkova, N, Coleman, R, et al. (2005) Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J Nutr 135, 722–728.
18 Perez-Jimenez, J & Saura-Calixto, F (2008) Grape products and cardiovascular disease risk factors. Nutr Res Rev 21, 158–173.
19 Dell'Agli, M, Busciala, A & Bosisio, E (2004) Vascular effects of wine polyphenols. Cardiovasc Res 63, 593–602.
20 Leifert, WR & Abeywardena, MY (2008) Cardioprotective actions of grape polyphenols. Nutr Res 28, 729–737.
21 Desch, S, Schmidt, J, Kobler, D, et al. (2010) Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens 23, 97–103.
22 Davidson, MH, Maki, KC, Dicklin, MR, et al. (2009) Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol 104, 936–942.
23 Aviram, M, Rosenblat, M, Gaitini, D, et al. (2004) Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23, 423–433.
24 Basu, A, Du, M, Sanchez, K, et al. (2011) Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27, 206–213.
25 Basu, A, Du, M, Leyva, MJ, et al. (2010) Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 140, 1582–1587.
26 Jimenez, JP, Serrano, J, Tabernero, M, et al. (2008) Effects of grape antioxidant dietary fiber in cardiovascular disease risk factors. Nutrition 24, 646–653.
27 Grundy, SM, Brewer, HB Jr, Cleeman, JI, et al. (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433–438.
28 Birjmohun, RS, van Leuven, SI, Levels, JH, et al. (2007) High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol 27, 1153–1158.
29 Nieuwdorp, M, van Haeften, TW, Gouverneur, MC, et al. (2006) Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55, 480–486.
30 Olszyna, DP, De, JE, Dekkers, PE, et al. (2001) Induction of cell-associated chemokines after endotoxin administration to healthy humans. Infect Immun 69, 2736–2738.
31 Estruch, R, Sacanella, E, Badia, E, et al. (2004) Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175, 117–123.
32 Arts, IC & Hollman, PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81, 1 Suppl., 317S–325S.
33 Sies, H, Schewe, T, Heiss, C, et al. (2005) Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr 81, 1 Suppl., 304S–312S.
34 Vita, JA (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81, 1 Suppl., 292S–297S.
35 Oak, MH, El, BJ & Schini-Kerth, VB (2005) Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 16, 1–8.
36 Nestel, P (2003) Isoflavones: their effects on cardiovascular risk and functions. Curr Opin Lipidol 14, 3–8.
37 Opie, LH & Lecour, S (2007) The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 28, 1683–1693.
38 Stoclet, JC, Chataigneau, T, Ndiaye, M, et al. (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500, 299–313.
39 Erridge, C, Attina, T, Spickett, CM, et al. (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286–1292.
40 DeFuria, J, Bennett, G, Strissel, KJ, et al. (2009) Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr 139, 1510–1516.
41 Feng, AN, Chen, YL, Chen, YT, et al. (1999) Red wine inhibits monocyte chemotactic protein-1 expression and modestly reduces neointimal hyperplasia after balloon injury in cholesterol-fed rabbits. Circulation 100, 2254–2259.
42 Manna, SK, Mukhopadhyay, A & Aggarwal, BB (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164, 6509–6519.
43 Blanco-Colio, LM, Munoz-Garcia, B, Martin-Ventura, JL, et al. (2007) Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet. Atherosclerosis 192, 335–341.
44 McDermott, DH, Yang, Q, Kathiresan, S, et al. (2005) CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112, 1113–1120.
45 Boring, L, Gosling, J, Cleary, M, et al. (1998) Decreased lesion formation in CCR2− / − mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894–897.
46 Gu, L, Okada, Y, Clinton, SK, et al. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2, 275–281.
47 Verschuren, L, Kooistra, T, Bernhagen, J, et al. (2009) MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 105, 99–107.
48 Chen, L, Yang, G, Zhang, X, et al. (2009) Induction of MIF expression by oxidized LDL via activation of NF-kappaB in vascular smooth muscle cells. Atherosclerosis 207, 428–433.
49 Kanda, H, Tateya, S, Tamori, Y, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494–1505.
50 Zhu, J, Yong, W, Wu, X, et al. (2008) Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun 369, 471–477.
51 Monagas, M, Khan, N, Andres-Lacueva, C, et al. (2009) Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells. Br J Nutr 102, 201–206.
52 Miles, EA, Zoubouli, P & Calder, PC (2005) Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition 21, 389–394.
53 Miles, EA, Zoubouli, P & Calder, PC (2005) Effects of polyphenols on human Th1 and Th2 cytokine production. Clin Nutr 24, 780–784.
54 Yang, CS, Sang, S, Lambert, JD, et al. (2008) Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 52, Suppl. 1, S139–S151.